ÀÏÀÚ ÆÄÀÏ Á¦¸ñ ±â°ü¸í
01-14    [Olix Pharmaceuticals (226950)] To step up as an RNAi platfo.. »ï¼ºÁõ±Ç
01-14    [Kolon TissueGene (950160)] 2026 US Phase III results: A key.. »ï¼ºÁõ±Ç
01-14    [D&D Pharmatech (347850)] Post-Metsera acquisition: Clinical.. »ï¼ºÁõ±Ç
01-14    [Healthcare] Who will be the real winners in 2026? »ï¼ºÁõ±Ç
01-14    [Aimed Bio (0009K0)] ADC pipeline expansion via screening te.. »ï¼ºÁõ±Ç
01-14    [AprilBio (397030)] Momentum acceleration through SAFA platf.. »ï¼ºÁõ±Ç
01-14    [ABL Bio (298380)] Confirmation of global demand for the BBB.. »ï¼ºÁõ±Ç
01-14    [OCI (456040)] ¹ÝµµÃ¼ ȣȲÀ¸·Î ÀÎÇÑ ¼öÇý ±â´ë »ï¼ºÁõ±Ç
01-14    ±¹³» ¸¶°¨½ÃȲ : ÄÚ½ºÇÇ ½Å°í°¡ ·¤¸® Áö¼Ó »ï¼ºÁõ±Ç
01-14    [OCI (456040)] Expected to benefit from the semiconductor bo.. »ï¼ºÁõ±Ç
01-14    [Studio Dragon (253450)] The proof is in the numbers »ï¼ºÁõ±Ç
01-14    [L&F (066970)] 4Q preview - Second straight beat expected »ï¼ºÁõ±Ç
01-14    [LG Chem (051910)] 4Q preview: Battery operations underperfo.. »ï¼ºÁõ±Ç
01-14    [Krafton (259960)]New-title visibility is key to rebound »ï¼ºÁõ±Ç
01-14    [±ÝÈ£¼®À¯È­ÇÐ (011780)] 4Q25 preview - ÀÏȸ¼º ¿äÀÎ ¿µÇ⠻ZÁõ±Ç
Àüü : 497  Ã³À½     ÀÌÀü    [11] [12] [13] [14] [15]    ´ÙÀ½    ³¡À¸·Î 

Ȩ > ¸®¼­Ä¡Á¤º¸ > ÃֱٰԽù°